| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Denali Therapeutics Inc. (DNLI) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 34 sells. DNLI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 26.00M | $625.21M | - | |
| CEO | 296.8K | $7.14M | - | |
| Other | 282.8K | $6.80M | - | |
| Other | 216.6K | $5.21M | - | |
| Dir | 38.2K | $918.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $19.08 | $143,089.26 | -0.2% | |
| Feb 5, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,334 | $18.72 | $343,299.88 | -0.2% | |
| Feb 5, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 17,500 | $18.72 | $327,589.07 | -95.8% | |
| Jan 11, 2019 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $20.37 | $152,750.00 | -0.4% | |
| Jan 4, 2019 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $19.43 | $356,288.16 | -0.1% | |
| Jan 4, 2019 | Ho Carole73 | Chief Medical Officer | Sale+OE | 14,502 | $19.55 | $283,506.05 | -4.6% | |
| Dec 12, 2018 | Schuth Alexander O.75 | COO And Secretary | Sell | 7,500 | $20.40 | $153,000.00 | -0.4% | |
| Dec 3, 2018 | Ho Carole73 | Chief Medical Officer | Sell | 17,500 | $18.45 | $322,834.10 | -5.6% | |
| Dec 3, 2018 | Watts Ryan J.77 | President And CEO | Sell | 18,333 | $18.43 | $337,937.85 | -0.3% | |
| Nov 15, 2018 | Ho Carole73 | Chief Medical Officer | Sell | 17,500 | $18.07 | $316,156.75 | -9.5% |